scispace - formally typeset
K

Katharina Rek

Researcher at Max Planck Society

Publications -  4
Citations -  173

Katharina Rek is an academic researcher from Max Planck Society. The author has contributed to research in topics: Personality disorders & Test validity. The author has an hindex of 3, co-authored 3 publications receiving 87 citations. Previous affiliations of Katharina Rek include University of Kassel.

Papers
More filters
Journal ArticleDOI

A Brief but Comprehensive Review of Research on the Alternative DSM-5 Model for Personality Disorders.

TL;DR: Both the Alternative DSM-5 Model for Personality Disorders and the chapter on personality disorders (PD) in the recent version of ICD-11 embody a shift from a categorical to a dimensional paradigm for the classification of PD.
Journal ArticleDOI

Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT.

TL;DR: The OPTIMA-Trial is the first to investigate the effectiveness of schema therapy as a treatment approach of MDD, to investigate mechanisms of change, and explore predictors of treatment response in an inpatient and day clinic setting by using such a wide range of parameters.
Journal ArticleDOI

A Psychometric Evaluation of the Standardized Assessment of Severity of Personality Disorder (SASPD) in Nonclinical and Clinical German Samples

TL;DR: The multidimensional structure and limited convergent and discriminant validity may hamper future usage of the SASPD as a short screening tool of PD severity according to ICD-11.
Journal ArticleDOI

Evaluating the role of maladaptive personality traits in schema therapy and cognitive behavioural therapy for depression.

TL;DR: In this article , the authors evaluated the role of personality pathology in the treatment of depression by testing whether maladaptive personality traits (1) predict changes in depression over treatment or vice versa, (2) change themselves over treatment, (3) change differentially depending on treatment with schema therapy (ST) or cognitive behavioural therapy (CBT), and (4) moderate the effectiveness of these treatments.